36 results
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing
424B4
8l6pfmufcctro19f
11 Oct 22
Prospectus supplement with pricing info
8:27am
8-K
EX-1.1
qkh8fekrja yw9bvshd8
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
8-K
EX-1.1
wd4o9d nz0nncm
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm